Daymark Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54.5M Sell
150,438
-68
-0% -$23.3K 1.33% 13
2026
Q1
$53M Sell
150,506
-1,795
-1% -$640K 1.67% 10
2025
Q4
$49.8M Sell
152,301
-122
-0.1% -$38.7K 1.59% 10
2025
Q3
$43M Buy
152,423
+8,334
+6% +$2.42M 1.46% 10
2025
Q2
$40.2M Buy
144,089
+329
+0.2% +$93.2K 1.53% 11
2025
Q1
$44.8M Sell
143,760
-95,096
-40% -$28.1M 1.92% 10
2024
Q4
$36.8M Buy
238,856
+7,684
+3% +$2.28M 1.56% 10
2024
Q3
$43M Buy
231,172
+2,977
+1% +$974K 1.82% 10
2024
Q2
$40.8M Buy
228,195
+3,299
+1% +$969K 1.87% 9
2024
Q1
$36.2M Buy
224,896
+2,340
+1% +$685K 1.95% 9
2023
Q4
$36M Sell
222,556
-849
-0.4% -$231K 2.21% 8
2023
Q3
$33.8M Buy
223,405
+111,603
+100% +$27.9M 2.33% 6
2023
Q2
$24.8M Buy
111,802
+33,869
+43% +$7.86M 1.84% 9
2023
Q1
$18.8M Buy
77,933
+4,024
+5% +$988K 2.5% 7
2022
Q4
$19.4M Buy
+73,909
New +$19.8M 3.43% 5

Other funds holding AMGN

Daymark Wealth Partners's AMGN Position: Q2 2026 in Review

Daymark Wealth Partners reduced its Amgen (AMGN) stake by 0.05% in Q2 2026, selling an estimated $23.3K and leaving 150,438 shares worth $54.5M. The position accounts for 1.33% of the portfolio, ranked #13.

Daymark Wealth Partners first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. 3,148 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Daymark Wealth Partners held 150,438 shares of Amgen worth $54.5M as of Q2 2026.
  • Daymark Wealth Partners sold 68 Amgen shares in Q2 2026, an estimated $23.3K.
  • Amgen made up 1.33% of Daymark Wealth Partners's portfolio in Q2 2026, its #13 holding.
  • Daymark Wealth Partners first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
  • 3,148 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Daymark Wealth Partners's 13F filing for Q2 2026, filed 31 Jul 2026.